ApoE e2 and aging-related outcomes in 379,000 UK Biobank participants
Figure 3.Associations between e2 (e2e2 or e2e3) and primary disease outcomes. Note: Traits labelled with an asterisk if significant at the Bonferroni-corrected level of 5% (*p<0.05/106).